Latest debt-to-equity ratio
Sarepta Therapeutics Debt-to-equity ratio
Direct answer
Sarepta Therapeutics's debt-to-equity ratio is 69.54%.
The verified market snapshot reports 69.54%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 27, 2026.
Get free Sarepta Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 69.54%
Explore related company data
View Sarepta Therapeutics's market capitalizationView Sarepta Therapeutics's price-to-book ratioView Sarepta Therapeutics's return on equityView Sarepta Therapeutics's 52-week price rangeView Sarepta Therapeutics's revenue growthView Sarepta Therapeutics's profit marginView all Sarepta Therapeutics key metricsReturn to Sarepta Therapeutics profile